Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Stoke Therapeutics
Company

Stoke Therapeutics

Tracked across 1 events · 8 articles · First seen Mar 04, 2026 · Last active Mar 05, 2026

Sentiment
85
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 85
Tech
Zorevunersen Shows Promise for Dravet Syndrome
Stoke Therapeutics is a biotechnology company that developed Zorevunersen in collaboration with Biogen. The positive trial results for Zorevunersen are a significant achievement for Stoke Therapeutics, potentially leading to a new approved treatment for Dravet syndrome.
Mar 04, 2026 · 8 articles
NEWSDESK
Track Stoke Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.